Latest Quarter
2025-12-31
Autonomix Medical Inc Common Stock (AMIX)
Revenue
$0.0
Net Income
-$3.3M
Operating Margin
N/A
Free Cash Flow
-$8.3M
Debt / Assets
17.4%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 4,000 | 2,000 | 0 | 0 |
| Gross Profit | -4,000 | -2,000 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 1,619,000 | 5,165,000 | 1,828,000 | 1,699,000 |
| Operating Expenses | 3,339,000 | 7,532,000 | 3,421,000 | 3,252,000 |
| Operating Income | -3,343,000 | -7,534,000 | -3,421,000 | -3,252,000 |
| Interest Expense | 0 | 0 | 0 | 46,000 |
| Income Before Tax | -3,261,000 | -7,451,000 | -3,337,000 | -3,191,000 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -3,261,000 | -7,451,000 | -3,337,000 | -3,191,000 |
| Per Share | ||||
| EPS | -0.36 | -1.38 | -1.07 | -1.81 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | |||
| R&D Expenses | 0 | 0 | 0 |
| SG&A Expenses | 6,863,000 | 5,249,000 | 1,333,000 |
| Operating Expenses | 11,588,000 | 12,030,000 | 1,990,000 |
| Operating Income | -11,588,000 | -12,030,000 | -1,990,000 |
| Interest Expense | 176,000 | 79,000 | 0 |
| Income Before Tax | -11,410,000 | -15,426,000 | -1,990,000 |
| Income Tax Expense | 0 | 0 | -1,990,000 |
| Net Income | -11,410,000 | -15,426,000 | -1,990,000 |
| Per Share | |||
| EPS | -6.46 | -21.10 | -0.11 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 9,136,000 | 8,608,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 9,609,000 | 9,391,000 |
| Property Plant Equipment | 21,000 | 16,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 9,806,000 | 9,407,000 |
| Liabilities | ||
| Account Payables | 676,000 | 492,000 |
| Short Term Debt | 0 | 0 |
| Total Current Liabilities | 1,707,000 | 777,000 |
| Long Term Debt | 0 | 1,002,000 |
| Total Liabilities | 1,707,000 | 1,779,000 |
| Shareholders Equity | ||
| Retained Earnings | -50,379,000 | -38,969,000 |
| Total Shareholders Equity | 8,099,000 | 7,628,000 |
| Balance Sheet (Annual) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 9,136,000 | 8,608,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 0 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 9,609,000 | 9,391,000 |
| Property Plant Equipment | 21,000 | 16,000 |
| Goodwill and Intangibles | 0 | 0 |
| Total Assets | 9,806,000 | 9,407,000 |
| Liabilities | ||
| Account Payables | 676,000 | 492,000 |
| Short Term Debt | 0 | 0 |
| Total Current Liabilities | 1,707,000 | 777,000 |
| Long Term Debt | 0 | 1,002,000 |
| Total Liabilities | 1,707,000 | 1,779,000 |
| Shareholders Equity | ||
| Retained Earnings | -50,379,000 | -38,969,000 |
| Total Shareholders Equity | 8,099,000 | 7,628,000 |
| Cash Flow Statement (Quarterly) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -11,410,000 | -15,426,000 |
| Depreciation & Amortization | 183,000 | 81,000 |
| Stock Based Compensation | 1,628,000 | 618 |
| Change in Working Capital | 1,240,000 | 79,000 |
| Operating Cash Flow | -8,258,000 | -6,648,000 |
| Investing Activities | ||
| Capital Expenditure | -14,000 | -19,000 |
| Investments | -14,000 | -19,000 |
| Investing Cash Flow | -14,000 | -19,000 |
| Financing Activities | ||
| Debt Repayment | 0 | 2,000,000 |
| Common Stock Issued/Repurchased | 10,027,000 | 13,706,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 8,800,000 | 14,410,000 |
| Summary | ||
| Free Cash Flow | -8,272,000 | -6,667,000 |
| Net Change in Cash | 528,000 | 7,743,000 |
| Cash Flow Statement (Annual) | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -11,410,000 | -15,426,000 |
| Depreciation & Amortization | 183,000 | 81,000 |
| Stock Based Compensation | 1,628,000 | 618 |
| Change in Working Capital | 1,240,000 | 79,000 |
| Operating Cash Flow | -8,258,000 | -6,648,000 |
| Investing Activities | ||
| Capital Expenditure | -14,000 | -19,000 |
| Investments | -14,000 | -19,000 |
| Investing Cash Flow | -14,000 | -19,000 |
| Financing Activities | ||
| Debt Repayment | 0 | 2,000,000 |
| Common Stock Issued/Repurchased | 10,027,000 | 13,706,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 8,800,000 | 14,410,000 |
| Summary | ||
| Free Cash Flow | -8,272,000 | -6,667,000 |
| Net Change in Cash | 528,000 | 7,743,000 |